Search by Drug Name or NDC

    NDC 42291-0417-90 Liothyronine Sodium 5 ug/1 Details

    Liothyronine Sodium 5 ug/1

    Liothyronine Sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is LIOTHYRONINE SODIUM.

    Product Information

    NDC 42291-0417
    Product ID 42291-417_d57cb601-da17-2ffd-e053-2995a90a3808
    Associated GPIs 28100020100305
    GCN Sequence Number 006659
    GCN Sequence Number Description liothyronine sodium TABLET 5 MCG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 26341
    HICL Sequence Number 002850
    HICL Sequence Number Description LIOTHYRONINE SODIUM
    Brand/Generic Generic
    Proprietary Name Liothyronine Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Liothyronine Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units ug/1
    Substance Name LIOTHYRONINE SODIUM
    Labeler Name AvKARE
    Pharmaceutical Class Triiodothyronine [CS], l-Triiodothyronine [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200295
    Listing Certified Through 2023-12-31

    Package

    NDC 42291-0417-90 (42291041790)

    NDC Package Code 42291-417-90
    Billing NDC 42291041790
    Package 90 TABLET in 1 BOTTLE (42291-417-90)
    Marketing Start Date 2018-10-11
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 77f9f96f-7895-723b-e053-2a91aa0a0d59 Details

    Revised: 1/2022